Vitamin D Supplementation Regimens in Breast Cancer Patients

Strategic Insights -

According to a recent study published in the journal Breast Cancer Research and Treatment, a significant number of breast cancer patients experience adverse effects due to vitamin D deficiency. The research aimed to assess vitamin D status among women diagnosed with breast cancer and to evaluate the effect of different vitamin D supplementation regimens on 25-OH vitamin D levels. The study included 224 women diagnosed with stage 0-III breast cancer, and the results highlight the importance of carefully considering vitamin D supplementation regimens in breast cancer treatment.

Key Takeaways:

  • The study found that 83% of breast cancer patients had vitamin D deficiency, defined as a 25-OH vitamin D level less than 20 ng/mL (Hollis et al., 1996).
  • Vitamin D deficiency was associated with bone loss, arthralgia, and falls in breast cancer patients.
  • The study evaluated the effect of daily low-dose and weekly high-dose vitamin D supplementation on 25-OH vitamin D levels.
  • The results showed that both daily low-dose and weekly high-dose vitamin D supplementation increased 25-OH vitamin D levels, with a significant difference observed between the two groups.
  • The researchers concluded that clinicians should carefully consider vitamin D supplementation regimens when treating vitamin D deficiency/insufficiency in breast cancer patients.
  • The study included 224 women diagnosed with stage 0-III breast cancer.
  • The researchers used 25-OH vitamin D levels to determine vitamin D status.
  • The study found that vitamin D deficiency was associated with bone loss, arthralgia, and falls in breast cancer patients.
  • The results showed that both daily low-dose and weekly high-dose vitamin D supplementation increased 25-OH vitamin D levels.

Statistics:

  • 83% of breast cancer patients had vitamin D deficiency (less than 20 ng/mL).
  • Number of breast cancer patients: 224.
  • Stages of breast cancer: 0-III.
  • Vitamin D levels were determined at baseline for all participants.
  • 25-OH vitamin D levels increased by 10 ng/mL in the daily low-dose vitamin D group and by 20 ng/mL in the weekly high-dose vitamin D group.

Sources:

  • Peppone, L.J., et al. (2011). The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Research and Treatment, 127(1), 171-177. doi: 10.1007/s10549-011-1514-x
  • Hollis, B. W., et al. (1996). Methods for the determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma. American Journal of Clinical Pathology, 105(2), 169-176.